Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2000 May-June;91(5-6) > Minerva Medica 2000 May-June;91(5-6):113-6

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,878


eTOC

 

CASE REPORT  


Minerva Medica 2000 May-June;91(5-6):113-6

Copyright © 2000 EDIZIONI MINERVA MEDICA

language: English

Moderate-dose intravenous immunoglobulin treatment of Job’s syndrome. Case report

Bilora F., Petrobelli F., Boccioletti V., Pomerri F.


PDF  


Job's syndrome (or hyperimmunoglobulinemia E syndrome) is a rare genetic disease characterized by skin eczema, pyogenic ''cold'' abscesses, sinopulmonary recidivous infections and high IgE plasma concentrations. Job's syndrome treatment is not satisfactory and cases studied are still limited. To describe the effects of IVIG therapy in a 37-year-old woman with hyper IgE syndrome and pneumonia. We measured IgE serum by immuno-fluorometric test and neutrophil chemotaxis by migration in a Boyden chamber before and after IVIG therapy. A moderate dose of IVIG resolved the clinical-radiological signs of the S. aureus bronchopneumonia and improved cytologic and biohumoral parameters. Intravenous immunoglobulins represent a useful treatment for acute pneumonia in Job's syndrome.

top of page

Publication History

Cite this article as

Corresponding author e-mail